Clinical TrialsSearch results
Number of results: 521
Recruiting
- A Randomized, Double-blind, Parallel Group, Multi-center, Phase III Study to Assess the Efficacy of Budesonide, Glycopyrronium, and Formoterol Fumarate Metered Dose Inhaler Relative to Glycopyrronium and Formoterol Fumarate MDI on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease (THARROS)
- COPD
- Ageishi Yuji
- 2024-03-27
Other
- A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy (SKYSCRAPER-15)
- Non-small Cell Lung Cancer (NSCLC)
- Raymond Meng
- 2024-03-14
Recruiting
- Preventive effect of low level laser for joint position sense deterioration induced by muscle fatigue
- Adult volunteers
- Adachi Nobuo
- 2024-03-07
Recruiting
- The usefulness of color Doppler in fetal echocardiography screening
- Heart Defects, Congenital
- Masumoto Akio
- 2024-02-08
Completed
- Twiddle Muff in supporting Chidren with DD
- Developmental Disabilities
- Nakamura Katsumi
- 2024-02-07
Recruiting
- Study of the efficacy of Bio-C Sealer in endodontic retreatment.
- apical periodontitis
- Saito Noriko
- 2024-01-22
Recruiting
- Survey on accommodating guests with food allergies
- food allergy
- Tsumaki Yoko
- 2024-01-10
Recruiting
- A study to determine the optimal dose of folic acid supplementation in patients with rheumatic diseases on methotrexate treatment
- Patients on methotrexate therapy regularly take folic acid supplementation to prevent its toxicity.
- Shintaro Hirata
- 2023-12-26
Recruiting
- Study on Pharmacokinetic Dynamics in Blood and Tissues of Continuous Administration of Beta-Lactam Antimicrobial Agents
- Diseases that are eligible for standby lower gastrointestinal (ileum, colon, rectum, anus) surgery.
- Ohge Hiroki
- 2023-12-21
Recruiting
- A Phase III, Randomized, Open-Label, Multicenter, Global Study of Volrustomig (MEDI5752) in Combination With Carboplatin Plus Pemetrexed Versus Platinum Plus Pemetrexed or Nivolumab Plus Ipilimumab in Participants With Unresectable Pleural Mesothelioma.
- Unresectable Pleural Mesothelioma
- Hibi Kazushige
- 2023-11-11